Nature of Endpoints in Market Access Agreements

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Value of Market Access and National Treatment Commitments in Services Trade Agreements

OECD Trade Policy Papers
2018English

Php352 - Success Factors for the Implementation of Market Access Agreements in Emerging Middle-Income Markets in Preparation for Outcomes Based Concepts

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmu31 - A Review of Managed Access Agreements (Maas) and Patient Access Schemes (Pass) in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Global Nuclear Markets – Market Arrangements and Service Agreements

2016English

Drug Repurposing in Pharmaceutical Industry and Its Impact on Market Access: Market Access Implications

Journal of Market Access & Health Policy
2014English

Concession Agreements and Market Entry in the Container Terminal Industry

2015English

Php365 - Trends and Characteristics of Managed Access Agreements Approved by Nice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PHP16 Generic Drug Market Access in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

It's a Question of Market Access

American Journal of International Law
LawInternational RelationsPolitical Science
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy